Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.

Authors :: Moorman AV
Enshaei A
Murdy D
Joy M
Boer JM
den Boer ML
Pieters R
de Haas V
Horstmann MA
Escherich G
Johansson B
Marquart HV
Schmiegelow K
Hancock J
Moppett J
Heyman M
Source :: Leukemia [Leukemia] 2024 Sep; Vol. 38 (9), pp. 2023-2026. Date of Electronic Publication: 2024 Jul 05.
Publication Year :: 2024

Subjects :: Humans
Male
Prognosis
Female
Adolescent
Child
Induction Chemotherapy
Adult
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma pathology
Neoplasm, Residual genetics
Neoplasm, Residual pathology

Full Text Access

Tools